Tristel (LON:TSTL)
383p+2.68%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“FDA entry driving 542% US revenue growth; CEO departure imminent with no successor named.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfe…
- Sector:
- Healthcare
- Industry:
- Medical Instruments & Supplies
- Market Cap:
- £198.2M
Recent dividends
- 19 Mar 20265.68p
- 27 Nov 20258.52p
- 20 Mar 20255.68p
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Tristel and 1,600+ UK and US stocks.
Start free